aana glp-1 guidelines The Agonists and Obesity: How Diabetes Drugs are Changing Non-Diabetic Lives — tl;dr pharmacy Researchers find GLP-1 medications safe

The dose schedule typically begins at 1mg weekly and escalates to 8mg or 12mg depending on the trial protocol

Semaglutide is a new second-generation GLP-1 agonist that was initially approved to treat diabetes but has been recently approved for obesity as well (FDA approval 6/4/21)

Remain upright after eating : Wait at least two to three hours after meals before lying down, and consider elevating the head of your bed by 1520 cm

It is a melanocortin receptor agonist with systemic effects that include nausea, appetite suppression, and sexual side effects in 2030% of subjects at standard doses

Take the Next Step If you are currently using weight-loss injections and considering gastric sleeve surgery, or if you want to understand whether injections could help prepare you for treatment, expert guidance is essential.